CRISPR screen reveals new targets in more than half of all squamous cell carcinomas
Tuesday, September 18, 2018 - 13:30
in Health & Medicine
Researchers sheds light on p63 activity in squamous cell carcinoma of the lung, providing an actionable path forward to drug development against this known cause of cancer.